Vimarsana
Biggest News Aggregation in the World

Page 25 - Regulated Information News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Regulated Information. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Regulated Information Today - Breaking & Trending Today

Oxurion NV: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLAS - Vimarsana News

Oxurion NV: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLAS

Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 8 convertible bonds in Oxurion resulting in a EUR 200,000 capital increase. This is part of Atlas Special

Safe group announces 2022 results | MarketScreener - Vimarsana News

Safe group announces 2022 results | MarketScreener

          Safe group announces 2022 results 2022 sales up +29% to €5.9mGross margin improvement of +5%Improvement in operating income recurring +19%... | June 5, 2023

BH Macro Limited - Conversion of Securities - Vimarsana News

BH Macro Limited - Conversion of Securities

BH Macro Limited - Conversion of Securities PR Newswire LONDON, United Kingdom, June 02 BH Macro Limited (the "Company") (a closed-ended collective investment

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC - Vimarsana News

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Regulated Information Leuven, BELGIUM, Boston, MA, US – June 1, 2023 – 7.00 PM CET Oxurion NV a biopharmaceutical company developing next generation standard of care ophthalmic... | June 1, 2023

Oxurion NV: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC - Vimarsana News

Oxurion NV: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Regulated Information Leuven, BELGIUM, Boston, MA, US - June 1, 2023 - 7.00 PM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic